Effects of IL-1β on the proliferation and apoptosis of gastric epithelial cells and acid secretion from isolated rabbit parietal cells

Molecular Medicine Reports

Volumn 7, Issue 1, 2013, Pages 299-305

  Guo, Tao ^a   Qian, Jia Ming ^a   Zhao, Yu Qing ^a   Li, Xiao Bo ^b   Zhang, Jian Zhong ^c  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Cyclooxygenase 2; Gastric cancer; H + K+ATPase; Helicobacter pylori; Interleukin 1

Indexed keywords

CYCLOOXYGENASE 2; HISTAMINE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; INTERLEUKIN 1BETA; MESSENGER RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FLOW CYTOMETRY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ACID SECRETION; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; STOMACH MUCOSA; STOMACH PARIETAL CELL; UPREGULATION;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CYCLOOXYGENASE 2; GASTRIC ACID; GENE EXPRESSION REGULATION; H(+)-K(+)-EXCHANGING ATPASE; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-1BETA; MALE; PARIETAL CELLS, GASTRIC; RABBITS;

EID: 84873850038     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1165     Document Type: Article

References (42)

1. Momtaz H, Souod N, Dabiri H and Sarshar M: Study of Helicobacter pylori genotype status in saliva, dental plaques, stool and gastric biopsy samples. World J Gastroenterol 18: 2105-2111, 2012.
2. Graham DY and Yamaoka Y: Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 5: 3-9, 2000.
3. Hitzler I, Sayi A, Kohler E, etal: Caspase-1 has both proinflammatory and regulatory properties in Helicobacter infections, which are differentially mediated by its substrates IL-1β and IL-18. J Immunol 188: 3594-3602, 2012.
4. Albaker WI: Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact? Saudi J Gastroenterol 17: 165-169, 2011.
5. El-Omar EM, Carrington M, Chow WH, etal: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402, 2000.
6. Tan IB, Ng I, Tai WM and Tan P: Understanding the genetic basis of gastric cancer: recent advances. Expert Rev Gastroenterol Hepatol 6: 335-341, 2012.
7. Cai C and Zhu X: The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Mol Med Report 5: 1191-1196, 2012.
8. Wang XC, Li Y, Fan LQ, etal: Integrase interactor 1 regulates proliferation, apoptosis and invasion in gastric cancer cells. Chin Med J (Engl) 125: 527-532, 2012.
9. Tu SP, Quante M, Bhagat G, etal: IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Cancer Res 71: 4247-4259, 2011.
10. Li XB, Qian JM, Chen YJ and Chen YF: Effect of lansoprazole on histamine-induced acid secretion in isolated rabbit parietal cells. Chin J Dig Dis 3: 47-50, 2002.
11. Sung JJ, Leung WK, Go MY, etal: Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 157: 729-735, 2000.
12. Pero R, Peluso S, Angrisano T, etal: Chromatin and DNA methylation dynamics of Helicobacter pylori-induced COX-2 activation. Int J Med Microbiol 301: 140-149, 2011.
13. Ohno R, Yoshinaga K, Fujita T, etal: Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 91: 1876-1881, 2001.
14. Zhang Y, Xu X and He P: Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells. Mol Med Report 4: 25-29, 2011.
15. Gou HF, Chen XC, Zhu J, etal: Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications. J Exp Clin Cancer Res 30: 14, 2011.
16. Huang DS, Shen KZ, Wei JF, etal: Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line Hep G2 through BCL-2. World J Gastroenterol 11: 204-207, 2005.
17. Nandi J, Das PK, Zinkievich JM, etal: Cyclo-oxygenase-1 inhibition increases acid secretion by modulating H+,K+-ATPase expression and activation in rabbit parietal cells. Clin Exp Pharmacol Physiol 36: 127-134, 2009.
18. Na HK, Inoue H and Surh YJ: ET-18-O-CH3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells. FEBS Lett 579: 6279-6287, 2005.
19. Timotheadou E, Skarlos DV, Samantas E, etal: Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients. Anticancer Res 27: 4481-4489, 2007.
20. Seo JH, Seo JY, Chung HY and Kim H: Effect of pertussis toxin and herbimycin A on proteinase-activated receptor 2-mediated cyclooxygenase 2 expression in Helicobacter pylori-infected gastric epithelial AGS cells. Yonsei Med J 52: 522-526, 2011.
21. Tatsuguchi A, Sakamoto C, Wada K, etal: Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 46: 782-789, 2000.
22. Zhang X, Zhong R, Zhang Z, etal: Interaction of cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer. Mol Carcinog 50: 876-883, 2011.
23. Liu W, Reinmuth N, Stoeltzing O, etal: Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res 63: 3632-3636, 2003.
24. Catley MC, Chivers JE, Cambridge LM, etal: IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. FEBS Lett 547: 75-79, 2003.
25. Etoh T, Shibuta K, Barnard GF, etal: Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res 6: 3545-3551, 2000.
26. Paduch R, Kandefer-Szerszeń M, Szuster-Ciesielska A and Plewka K: Transforming growth factor-beta1 modulates metalloproteinase-2 and-9, nitric oxide, Rho A and alpha-smooth muscle actin expression in colon adenocarcinoma cells. Cell Biol Int 34: 213-223, 2010.
27. Maihöfner C, Charalambous MP, Bhambra U, etal: Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis 24: 665-671, 2003.
28. Sugimoto M, Furuta T, Shirai N, etal: Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy. Helicobacter 12: 317-323, 2007.
29. Oridate N, Takeda H, Yamamoto J, etal: Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms. Laryngoscope 116: 547-553, 2006.
30. Zhu H, Hart CA, Sales D and Roberts NB: Bacterial killing in gastric juice-effect of pH and pepsin on Escherichia coli and Helicobacter pylori. J Med Microbiol 55: 1265-1270, 2006.
31. Takashima M, Furuta T, Hanai H, etal: Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 48: 765-773, 2001.
32. Nguyen NV, Gleeson PA, Courtois-Coutry N, etal: Gastric parietal cell acid secretion in mice can be regulated independently of H/K ATPase endocytosis. Gastroenterology 127: 145-154, 2004.
33. Wei XH, Yang T, Wu Q, etal: Peri-sciatic administration of recombinant rat IL-1β induces mechanical allodynia by activation of src-family kinases in spinal microglia in rats. Exp Neurol 234: 389-397, 2012.
34. Shibata Y, Kasai H, Shimada M, etal: IL-1β stimulates IL-8 production, including prostaglandin E2 receptor EP4-triggered pathways, in synoviocyte MH7A cells. Mol Med Report 2: 359-363, 2009.
35. Sugimoto M, Furuta T and Yamaoka Y: Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol 24: 1725-1732, 2009.
36. Kidd M, Gustafsson BI, Drozdov I and Modlin IM: IL1beta-and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 21: 439-450, 2009.
37. Beales IL: Gastrin and interleukin-1beta stimulate growth factor secretion from cultured rabbit gastric parietal cells. Life Sci 75: 2983-2995, 2004.
38. Shimamoto C, Nakanishi Y, Katsu K, etal: Prostaglandin E2 release in gastric antral mucosa of guinea-pigs: basal PGE2 release by cyclo-oxygenase 2 and ACh-stimulated PGE2 release by cyclo-oxygenase 1. Exp Physiol 91: 1015-1024, 2006.
39. Zinkievich JM, George S, Jha S, etal: Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats. Clin Exp Pharmacol Physiol 37: 654-661, 2010.
40. Sekiguchi F, Ohi A, Maeda Y, etal: Delayed production of arachidonic acid contributes to the delay of proteinase-activated receptor-1 (PAR1)-triggered prostaglandin E2 release in rat gastric epithelial RGM1 cells. J Cell Biochem 112: 909-915, 2011.
41. Xiao F, Furuta T, Takashima M, etal: Effects of cyclooxygenase-2 inhibitor on gastric acid secretion in Helicobacter pylori-infected C57BL/6 mice. Scand J Gastroenterol 36: 577-583, 2001.
42. Pal J, Sanal MG and Gopal GJ: Vitamin-C as anti-Helicobacter pylori agent: More prophylactic than curative-Critical review. Indian J Pharmacol 43: 624-627, 2011.